Inactive Instrument
Raptor Pharmaceutical Corp Stock
Stocks
US75382F1066
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Hoelscher
DFI | Director of Finance/CFO | 61 | 2016-10-24 |
| Corporate Officer/Principal | 64 | 2013-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Hoelscher
BRD | Director/Board Member | 61 | 2016-10-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.83% | +3.51% | +55.00% | +62.02% | 66.7B | |
| +0.02% | +1.07% | +11.72% | +74.73% | 56.88B | |
| -1.34% | +2.98% | +25.08% | +98.39% | 56.53B | |
| +5.09% | +9.89% | +27.19% | +103.27% | 46.49B | |
| +2.62% | +1.68% | +29.16% | +36.08% | 44.8B | |
| +8.24% | +0.51% | +215.16% | +807.84% | 41.59B | |
| -1.86% | +10.13% | +28.14% | +53.61% | 35.35B | |
| -2.97% | -9.84% | +90.91% | +61.94% | 33.29B | |
| +5.19% | +1.62% | -39.69% | +381.71% | 25.1B | |
| Average | +1.13% | +2.65% | +49.18% | +186.62% | 45.19B | |
| Weighted average by Cap. | +0.65% | +3.07% | +49.90% | +165.96% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
